Catalyst Biosciences Inc (CBIO)

Catalyst Biosciences (CBIO) Income Statement


Catalyst Biosciences Income Statement

Last quarter (Q1 2023), Catalyst Biosciences's total revenue was $96.00K, a decrease of -87.91% from the same quarter last year. In Q1, Catalyst Biosciences's net income was $260.00K. See Catalyst Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 96.00K$ 794.00K$ 7.34M$ 20.95M$ 0.00$ 6.00K
Cost of Revenue
-$ -798.00K$ 7.38M$ 9.16M$ 0.00-
Gross Profit
$ 96.00K$ -4.00K$ -42.00K$ 11.79M$ 0.00-
Operating Expense
$ -24.84M$ -9.40M$ 87.85M$ 69.16M$ 57.28M$ 33.83M
Operating Income
$ -55.56M$ -65.80M$ -87.89M$ -57.37M$ -57.28M$ -33.82M
Net Non Operating Interest Income Expense
$ 388.00K$ 537.00K$ 39.00K$ 561.00K$ 2.15M$ 2.23M
Other Income Expense
$ 52.55M$ -57.19M$ -78.00K$ 568.00K$ -46.00K$ 1.54M
Pretax Income
$ 7.30M$ -7.89M$ -87.93M$ -56.24M$ -55.18M$ -30.05M
Tax Provision
$ 362.00K$ 348.00K----
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ 6.55M$ -8.24M$ -87.93M$ -56.24M$ -55.18M$ -30.05M
Basic EPS
$ -0.25$ -0.26$ -2.87$ -2.93$ -4.60$ -2.68
Diluted EPS
$ 0.21$ -0.26$ -2.87$ -2.93$ -4.60$ -2.68
Basic Average Shares
$ 132.27M$ 31.55M$ 30.64M$ 19.18M$ 12.00M$ 11.21M
Diluted Average Shares
$ 132.50M$ 31.55M$ 30.64M$ 19.18M$ 12.00M$ 11.21M
Dividend Per Share
$ -1.19$ 0.24----
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ -24.84M$ -10.20M$ 95.23M$ 78.32M$ 57.28M$ 33.83M
Net Income From Continuing And Discontinued Operation
$ 6.55M$ -8.24M$ -87.93M$ -56.24M$ -55.18M$ -30.05M
Normalized Income
$ 12.40M-$ -87.93M$ -56.24M$ -55.18M$ -29.94M
Interest Expense
$ 1.00K-----
$ -50.05M$ -8.43M$ -87.89M$ -57.37M$ -57.28M$ -33.82M
$ -49.93M$ -8.20M$ -87.60M$ -57.23M$ -57.13M$ -33.67M
Currency in USD

Catalyst Biosciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis